10.1016/j.canlet.2005.11.033 164 YewE
Route of Administration and Practical Research Considerations BPC-157 is administered i.p., i.v., i.m., or orally in preclinical models oral BPC-157 retains CNS activity in drinking water models (10 g/kg/day), suggesting either partial absorption or robust luminal effects driving vagal signalling
Oral Supplements: A Quick Comparison For people with a confirmed deficiency, especially those with absorption problems, injections generally act faster than oral supplements: Injections: bypass the gut, reliably reach the bloodstream, and often produce noticeable changes in energy and mental clarity within days for those who are deficient
The lipid present in the nano-lipid carrier mimics the mechanism of skin lipids that enhances the permeation of these nanocarriers inside the skin layer and enhances their retention, as well as extends the therapeutic effect
In some cases, it can lead to pernicious anemia, where the body cant make enough red blood cells